Literature DB >> 11152930

Oxidized lipoprotein(a) enhanced the expression of P-selectin in cultured human umbilical vein endothelial cells.

S P Zhao1, D Y Xu.   

Abstract

Lipoprotein(a) [Lp(a)] has been demonstrated to be an independent risk factor for coronary heart disease. However, the precise mechanism by which it contributes to the development of atherosclerosis remains unclear. P-selectin is one of the major adhesion molecules to mediate the interaction between monocytes, platelets and endothelial cells. Increased expression of P-selectin has been frequently found in atherosclerotic lesions. The present study assessed the effects of native and oxidized LDL (n-LDL and ox-LDL) and Lp(a) (n-Lp(a) and ox-Lp(a)) on the expression of P-selectin in cultured human umbilical vein endothelial cells (HUVECs). Cell ELISA was used to measure the expression of P-selectin in HUVECs and monocyte adhesion assay was used to detect whether the P-selectin expressed in HUVECs was functional. P-selectin mRNA expression in HUVECs was determined by Northern blot. Results showed that P-selectin protein expression was not influenced by n-LDL, but was moderately increased by ox-LDL and n-Lp(a). ox-Lp(a) was the most potent stimulus for P-selectin expression, increasing it in HUVECs by 144 +/- 10% at 10 nmol/l and 202 +/- 22% at 20 nmol/l. In addition, it showed that dose dependency induced monocyte adherence to endothelial cells after incubation of HUVECs with ox-Lp(a). Northern blot analysis demonstrated that the amount of P-selectin mRNA was markedly increased after treatment with ox-Lp(a) but not with n-LDL, ox-LDL and n-Lp(a). These results demonstrate that ox-Lp(a) can induce P-selectin expression in HUVECs, which may thereby influence the pathogenesis of athersclerosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11152930     DOI: 10.1016/s0049-3848(00)00363-7

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  9 in total

Review 1.  Platelet-endothelial interactions in atherosclerosis.

Authors:  B S Sachais
Journal:  Curr Atheroscler Rep       Date:  2001-09       Impact factor: 5.113

2.  Simultaneous isolation of endothelial and smooth muscle cells from human umbilical artery or vein and their growth response to low-density lipoproteins.

Authors:  Gudrun Ulrich-Merzenich; Christine Metzner; Ramesh R Bhonde; Gerhard Malsch; Beate Schiermeyer; Hans Vetter
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002-05       Impact factor: 2.416

3.  Lipoprotein(a) predicts progression of carotid artery intima-media thickening in patients with type 2 diabetes: A four-year follow-up.

Authors:  Jozo Boras; Spomenka Ljubic; Nikica Car; Zeljko Metelko; Mladen Petrovecki; Marijana Vucic Lovrencic; Zeljko Reiner
Journal:  Wien Klin Wochenschr       Date:  2010-03       Impact factor: 1.704

4.  Chronic hyperglicemia and nitric oxide bioavailability play a pivotal role in pro-atherogenic vascular modifications.

Authors:  Assunta Pandolfi; Elena Anna De Filippis
Journal:  Genes Nutr       Date:  2007-10-17       Impact factor: 5.523

5.  Apolipoprotein(a), through its strong lysine-binding site in KIV(10'), mediates increased endothelial cell contraction and permeability via a Rho/Rho kinase/MYPT1-dependent pathway.

Authors:  Taewoo Cho; Yoojin Jung; Marlys L Koschinsky
Journal:  J Biol Chem       Date:  2008-09-05       Impact factor: 5.157

6.  Mechanical regulation of calcium signaling of HL-60 on P-selectin under flow.

Authors:  Bing Huang; Yingchen Ling; Jiangguo Lin; Ying Fang; Jianhua Wu
Journal:  Biomed Eng Online       Date:  2016-12-28       Impact factor: 2.819

7.  Lipoprotein(a), an Opsonin, Enhances the Phagocytosis of Nontypeable Haemophilus influenzae by Macrophages.

Authors:  Zhi Liu; Yuxin Li; Yu Wang; Zhe Liu; Yan Su; Qiang Ma; Runlin Han
Journal:  J Immunol Res       Date:  2021-11-02       Impact factor: 4.818

Review 8.  Lipoprotein(a) in cardiovascular diseases.

Authors:  Michele Malaguarnera; Marco Vacante; Cristina Russo; Giulia Malaguarnera; Tijana Antic; Lucia Malaguarnera; Rita Bella; Giovanni Pennisi; Fabio Galvano; Alessandro Frigiola
Journal:  Biomed Res Int       Date:  2012-12-30       Impact factor: 3.411

Review 9.  Lipoprotein(a) the Insurgent: A New Insight into the Structure, Function, Metabolism, Pathogenicity, and Medications Affecting Lipoprotein(a) Molecule.

Authors:  Motasim M Jawi; Jiri Frohlich; Sammy Y Chan
Journal:  J Lipids       Date:  2020-02-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.